Teacher Retirement System of Texas Has $214,000 Stock Holdings in Liquidia Corporation $LQDA

Teacher Retirement System of Texas increased its position in Liquidia Corporation (NASDAQ:LQDA) by 25.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 17,185 shares of the company’s stock after buying an additional 3,478 shares during the quarter. Teacher Retirement System of Texas’ holdings in Liquidia were worth $214,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in the business. Y Intercept Hong Kong Ltd bought a new stake in Liquidia during the 2nd quarter worth approximately $775,000. KLP Kapitalforvaltning AS raised its stake in shares of Liquidia by 26.9% during the second quarter. KLP Kapitalforvaltning AS now owns 13,200 shares of the company’s stock valued at $164,000 after acquiring an additional 2,800 shares during the last quarter. Ballentine Partners LLC lifted its holdings in shares of Liquidia by 10.2% during the second quarter. Ballentine Partners LLC now owns 12,139 shares of the company’s stock worth $151,000 after purchasing an additional 1,119 shares during the period. Whitcomb & Hess Inc. grew its stake in shares of Liquidia by 30.6% in the second quarter. Whitcomb & Hess Inc. now owns 27,827 shares of the company’s stock worth $347,000 after purchasing an additional 6,527 shares during the last quarter. Finally, Rhumbline Advisers grew its stake in shares of Liquidia by 6.0% in the first quarter. Rhumbline Advisers now owns 85,463 shares of the company’s stock worth $1,261,000 after purchasing an additional 4,811 shares during the last quarter. Institutional investors own 64.54% of the company’s stock.

Insider Buying and Selling at Liquidia

In other news, Director Raman Singh sold 45,524 shares of the stock in a transaction dated Monday, September 15th. The shares were sold at an average price of $25.81, for a total transaction of $1,174,974.44. Following the transaction, the director owned 31,255 shares of the company’s stock, valued at $806,691.55. This represents a 59.29% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Paul B. Manning sold 328,268 shares of the business’s stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $28.78, for a total value of $9,447,553.04. Following the completion of the sale, the director directly owned 430,828 shares of the company’s stock, valued at $12,399,229.84. The trade was a 43.24% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 920,522 shares of company stock valued at $25,512,207 over the last 90 days. Insiders own 30.10% of the company’s stock.

Liquidia Stock Up 1.9%

Shares of Liquidia stock opened at $27.78 on Wednesday. The firm has a market cap of $2.42 billion, a price-to-earnings ratio of -19.29 and a beta of 0.12. The stock’s 50-day moving average is $24.47 and its 200 day moving average is $20.07. The company has a debt-to-equity ratio of 6.19, a current ratio of 2.20 and a quick ratio of 1.96. Liquidia Corporation has a one year low of $9.71 and a one year high of $29.94.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings results on Monday, November 3rd. The company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.45) by $0.41. The firm had revenue of $54.34 million for the quarter, compared to analyst estimates of $18.86 million. Liquidia had a negative return on equity of 296.78% and a negative net margin of 176.04%.Liquidia’s revenue for the quarter was up 1106.7% on a year-over-year basis. Equities research analysts anticipate that Liquidia Corporation will post -1.51 EPS for the current year.

Analyst Ratings Changes

Several brokerages recently issued reports on LQDA. Wall Street Zen raised Liquidia from a “hold” rating to a “buy” rating in a research report on Saturday. Raymond James Financial reissued a “strong-buy” rating and issued a $47.00 price target on shares of Liquidia in a research note on Tuesday, November 4th. BTIG Research reaffirmed a “buy” rating and issued a $49.00 price objective on shares of Liquidia in a research note on Tuesday, November 4th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Liquidia in a report on Wednesday, October 8th. Finally, HC Wainwright raised their price target on shares of Liquidia from $35.00 to $50.00 and gave the stock a “buy” rating in a report on Tuesday, November 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have given a Sell rating to the company. According to MarketBeat.com, Liquidia presently has an average rating of “Moderate Buy” and an average target price of $38.56.

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).